Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05220904
Other study ID # 2021KYPJ203
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date February 5, 2022
Est. completion date July 30, 2024

Study information

Verified date November 2023
Source Zhongshan Ophthalmic Center, Sun Yat-sen University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This project aims at non-progressive keratoconus patients with unsatisfactory visual acuity corrected by spectacles, and explores the effectiveness and maintenance of visual acuity improved by perceptual learning.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 54
Est. completion date July 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers No
Gender All
Age group 9 Years and older
Eligibility Inclusion Criteria: 1. Aged 9 years or older; 2. Has been diagnosed as Keratoconus,BAD-D=2.6; 3. Change of Kmax < 1.0 D and change of BAD-D <0.4175 betweem the last two Pentacam result; 4. The best corrected visual acuity of both eyes was between 0.1 and 1.0; 5. Has voluntarily agreed to participate in the study by signing the statement of informed consent. Exclusion Criteria: 1. Has history of acute keratoconus; 2. Has other eye diseases or other diseases/conditions causing vision loss; 3. Has eye surgery history in the past 1year; 4. Is currently using local/systemic medications or other interventions that may affect visual function; 5. Receiving other treatments that may affect the results of this study, such as contact lenses during the study; 6. Has any known neurological diseases; 7. Participating in other studies currently that may affect the results of this study; 8. Study other reasons that the physician considers inappropriate for inclusion in the program.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
spectacles
Spectacle is the the most common treatment for refractive errors.
perceptual learning
Blurred vision from the eyes can be improved by enhancing the brain's visual processing.

Locations

Country Name City State
China Zhongshan Ophthalmic Center, Sun Yat-sen University Guangzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Zhongshan Ophthalmic Center, Sun Yat-sen University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary 3-months corrected visual acuity Mean changes of best corrected visual acuity between 3 months after perceptual learning training and baseline values. baseline;3 months.
Secondary corrected visual acuity of other time frame Mean changes of best corrected visual acuity for 6,9,15 months. 6,9,15 months
Secondary ucorrected visual acuity (UCVA) Mean changes of ucorrected visual acuity (UCVA) for 3,6,9,15 months. 3,6,9,15 months
Secondary contrast sensitivity function (CSF) Mean changes of contrast sensitivity function (CSF) for 3,6,9,15 months. 3,6,9,15 months
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04598932 - Corneal Biomechanical Analysis Using Brillouin Microscopy
Completed NCT05748002 - Evaluation of Morphology Abnormal Cornea Stability With Corneal Biomechanical